Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-12.78	38.25	43.86
Graham Fair Price	-38.66	14.99	24.44
PEG	694.94	-0.13	0.02
Price/Book	-2.65	1.84	1.89
Price/Cash Flow	-19.15	85.25	105.45
Prices/Earnings	157.13	18.04	-7.02
Price/Sales	-4.71	5.45	5.72
Price/FCF	-19.15	85.25	105.45
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	24.36	0.32	0.25
Operating Margin	17.49	0.14	0.12
ROA	-62.09	< 0.005	-0.03
ROE	-0.07	0.03	-62.14
ROIC	0.02	0.02	10.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.09	87.79
Dividends QOQ	< 0.005	< 0.005	211.25
EBIT QOQ	0.05	0.19	325.44
EPS QOQ	-4.27	1.38	-67.65
FCF QOQ	-0.38	0.20	-48.86
Revenue QOQ	< 0.005	0.01	62.82
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	86.68	94.10	8.56
Days Sales Outstanding (DSO)	67.48	67.95	0.70
Inventory Turnover	1.04	0.96	-7.88
Debt/Capitalization	0.53	0.53	0.51
Quick Ratio	1.52	1.54	1.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.83	19.77	-0.31
Cash	3.36	3.06	-9.03
Capex	-0.31	-0.28	9.02
Free Cash Flow	0.36	0.43	20.04
Revenue	6.57	6.69	1.84
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.55	2.64	3.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.94	13.35	-10.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating